IPCA Labs, Paytm Surge in Nifty Midcap 150 RallyStrong Performances Drive Midcap Gains, Ipca Labs Reports Robust Financial GrowthDuring Thursday’s trading session, several stocks posted significant gains, with Ipca Labs and One 97 Paytm leading the Nifty Midcap 150 index. By 2:30 pm, Ipca Labs traded at Rs 1,529.50, up 4.77%, while One 97 Paytm reached Rs 1,113.45, gaining 3.95%. Other notable performers included Coromandel International, Indian Bank, and Fortis Healthcare, reflecting strong momentum in the midcap sector.
Recommended Read: Bajaj Finance Reports Strong Q1FY26 Results
Ipca Labs Financial Highlights
Ipca Labs has shown steady financial growth across recent quarters. For the quarter ending March 2025, consolidated revenue reached Rs 2,246.69 Crore, up from Rs 2,033.01 Crore in March 2024. However, net profit for the same period dipped to Rs 65.78 Crore from Rs 72.91 Crore the previous year. The EPS increased to Rs 2.67 from Rs 2.35 in March 2024.
On an annual basis, Ipca Labs reported consolidated revenue of Rs 8,939.59 Crore in 2025, a significant rise from Rs 7,705.04 Crore in 2024. Net profit grew from Rs 529.21 Crore in 2024 to Rs 787.53 Crore in 2025, with EPS climbing from Rs 25.82 to Rs 35.14 over the same period.
Click here to explore other:
